WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics (Q44612816)
Jump to navigation
Jump to search
scientific article published on 20 December 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics |
scientific article published on 20 December 2008 |
Statements
1 reference
WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics (English)
1 reference
Steven M Grauer
1 reference
Radka Graf
1 reference
Rachel Navarra
1 reference
Amy Sung
1 reference
Sheree F Logue
1 reference
Gary Stack
1 reference
Christine Huselton
1 reference
Zhi Liu
1 reference
Thomas A Comery
1 reference
Karen L Marquis
1 reference
Sharon Rosenzweig-Lipson
1 reference
20 December 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference